Intranasal Midazolam Uncooperative Child — FRCA Final MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Intranasal midazolam 0.2-0.5 mg/kg as premedication
Intranasal midazolam (0.2-0.5 mg/kg, maximum 10 mg) is an effective non-invasive premedication for uncooperative children who will not accept oral, IV, or inhalational routes. It provides anxiolysis and sedation within 10-15 minutes via nasal mucosal absorption, often enabling cooperative induction (IV or inhalational). Intranasal dexmedetomidine (2-4 mcg/kg) is an alternative. If intranasal premedication fails, IM ketamine may be used as a rescue technique. Physical restraint for IV cannulation should be avoided unless medically essential and all alternatives have been exhausted. ASD-specific considerations include: minimal sensory stimulation, familiar objects, and parental presence.
Reference: APA – 2019 – Premedication in children; RCOA – 2023 – Paediatric anaesthesia for children with ASD